We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Vaping hub (19)
- Compliance and enforcement (18)
- Advertising (16)
- Legislation (15)
- Safety monitoring and information (12)
- Manufacturing (11)
- COVID-19 (8)
- Import and export (8)
- Labelling and packaging (8)
- Medicinal cannabis hub (6)
- Scheduling (national classification system) (5)
- Weight loss products (3)
- Clinical trials (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Shortages and supply disruptions (1)
- Sunscreens (1)
Search
119 result(s) found, displaying 101 to 119
-
Media releasesWe have updated our guidance on advertising cosmetic injectables to ensure advertising rules are applied consistently across all industries that deal with therapeutic goods.
-
Regulatory decision noticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
Regulatory decision noticesThe TGA and Health Canada have signed a Memorandum of Understanding to further increase collaboration and reliance on Good Manufacturing Practice inspections conducted in countries outside each other's borders.
-
Regulatory decision noticesFrom 3 June 2024, we will be using a new Good Manufacturing Practice (GMP) guide for medicines, active pharmaceutical ingredients and sunscreens.
-
Media releasesTherapeutic goods and records have been seized from a pharmacy in Melbourne. This is part of our investigation into the alleged unlawful manufacture, supply and export of therapeutic goods.
-
Media releasesThe targeted consultation is part of a proposal to change the Therapeutic Goods Regulations 1990 to mitigate safety risks in the compounding of GLP-1 RAs.
-
Media releasesThe TGA has issued 2 infringement notices totalling $37,560 to Queensland-based company Akula Foods Pty Ltd for the alleged unlawful import of unregistered complementary medicines
-
Media releasesThe TGA has issued 4 infringement notices totalling $75,120 to Liquefy Health Pty Ltd for the alleged unlawful importation and advertising of unapproved complementary medicines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesAnnouncement about the launch of the pilot Single Inspection Program, a global approach to Good Manufacturing Practice inspections of third country manufacturers.
-
Media releasesThe TGA has issued 13 infringement notices totalling $42,900 to a New South Wales-based individual for the alleged unlawful advertisement and supply of erectile dysfunction medicines.
-
Media releasesThe Australian Border Force (ABF) and partners have seized more than five and a half million cigarette sticks and prevented hundreds of thousands of prohibited vapes and drug items from reaching the streets of Sydney.
-
Regulatory decision noticesThis instrument is made under regulation 97 of the Therapeutic Goods Regulations 1990.
-
Regulatory decision noticesThis instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has issued 18 infringement notices totalling $157,752 to Kilpatrick & Douglas Pty Ltd and two directors, for the alleged unlawful advertising of nicotine vapes
-
News articlesOn 1 January 2024, as part of the reforms to the regulation of vaping products, the Advertising Permission for Nicotine was repealed.
-
Media releasesThe TGA with the assistance of NSW Police have seized 478 sport supplements containing potentially dangerous substances from a Sydney retail store.
-
Media releasesWe issued an infringement notice for $13,320 to the New South Wales based company Marvel Health (Australia) Pty Ltd. This was for an alleged failure to comply with a notice to provide information about a complementary (listed) medicine.